Nobivac Intra-Trac KC Intranasal 25x1ml Vials

Prescription items are NON-RETURNABLE and NON REFUNDABLE **Vaccine orders are shipped Monday, Tuesday, and Wednesday with 2 day shipping.** **All vaccines shipping to the state of Minnesota require a written prescription.** Nobivac Intra-Trac KC Dog Vaccine 25 X 1 Dose The Nobivac Intra-Trac KC Dog Vaccine is suggested to help control and avoid a disease, which is related with canine parainfluenza and Bordetella bronchiseptica infection in healthy dogs, that are three weeks of age or older. These agents prove fruitful, as they play a positive role in the etiology of the condition known as canine cough. Features:

• Vaccine designed for healthy dogs that are three weeks of age or older
• Protects against canine parainfluenza and Bordetella bronchiseptica infection

Item Specifications: Size: 25 x 1 ml single dose vials with sterile diluent Ingredients: Canine parainfluenza, modified live virus and Bordetella bronchiseptica avirulent live culture. This vaccine contains penicillin streptomycin and nystatin as preservatives. How to Vaccinate: Instill the rehydrated vaccine into one or both nostrils of dogs. When to Vaccinate: Vaccinate dogs at 3 weeks of age or older. Revaccinate annually. Caution: This product is designed for intranasal use only with the enclosed applicators. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting diarrhea lethargy inappetence jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin tetracycline or trimethoprim/sulfa may be indicated. Post vaccinal reactions consisting of mild canine cough syndrome may occur following use of this vaccine. If anaphylactoid reaction occurs use epinephrine. For additional product information, see clickable links listed under Downloadable Resources to the right.